Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hims & Hers Health Inc.

57.82
+1.622.88%
Post-market: 57.51-0.3132-0.54%19:59 EDT
Volume:36.25M
Turnover:2.10B
Market Cap:13.07B
PE:73.30
High:59.36
Open:56.23
Low:56.17
Close:56.20
52wk High:72.98
52wk Low:15.73
Shares:226.02M
Float Shares:197.51M
Volume Ratio:1.02
T/O Rate:18.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7888
EPS(LYR):0.5837
ROE:41.88%
ROA:6.94%
PB:23.22
PE(LYR):99.06

Loading ...

Stock Track | Hims & Hers Health (HIMS) Soars 5.04% on Strong Growth Prospects Despite Regulatory Challenges

Stock Track
·
Sep 19

Moderately bullish activity in Hims and Hers Health with shares up 11.57%

TIPRANKS
·
Sep 19

U.S. Stocks to Watch: Nvidia, Baidu, Alibaba, NIO, Workday, Hims, New Fortress Energy, and More

Dow Jones
·
Sep 17

Premarket Movers | New Fortress Energy Stock Soars 62%; American Resources Jumps 3%; HIMS Drops Another 2.2% While Novo Gains 1.4%

Tiger Newspress
·
Sep 17

Hims & Hers CEO Andrew Dudum : I’m Looking Forward to Continuing That Work With the FDA

THOMSON REUTERS
·
Sep 17

Hims & Hers CEO Andrew Dudum: Around 100 FDA Letters Went Out Last Week to Companies Across the Industry, We Got One

THOMSON REUTERS
·
Sep 17

Hims & Hers Stock (HIMS) Slumps as FDA Slams Its ‘False’ Weight Loss Drug Products

TIPRANKS
·
Sep 17

Hims & Hers Health Shares Fall 6.7% After US FDA Warns of Misleading Weight‑Loss Drug Claims

THOMSON REUTERS
·
Sep 17

Top Midday Stories: Judge Tosses Terrorism Charges Against Alleged Shooter of UnitedHealth Executive; Hims Shares Fall After FDA Warning Letter

MT Newswires Live
·
Sep 17

FDA: Sends Warning Letter to Hims & Hers Health on Offers Various Compounded Drug Products, Including Semaglutide

THOMSON REUTERS
·
Sep 17

Hims & Hers Health Receives Warning Letter From FDA; Shares Fall over 7%

MT Newswires Live
·
Sep 16

Stock Track | Hims & Hers Health Plummets 8.12% After FDA Warning on Weight Loss Drug Promotion

Stock Track
·
Sep 16

Hims & Hers Health Reportedly Receives FDA Warning Letter Over Marketing Claims for Semaglutide Products

MT Newswires Live
·
Sep 16

Hims & Hers Health Inc. (HIMS.US) Drops Over 7% Following FDA Warning on Weight Loss Drug Promotion

Stock News
·
Sep 16

Leverage Shares Launches First 3x Single-Stock ETPs on HOOD, HIMS, UNH and Others

TIPRANKS
·
Sep 16

Moderately bullish activity in Hims and Hers Health with shares down 2.75%

TIPRANKS
·
Sep 16

FDA Flags Hims & Hers (HIMS) Super Bowl Ad for Violating Drug Promotion Rules

TIPRANKS
·
Sep 16

Hims & Hers Is in the FDA's Crosshairs. It's a Risk to the Stock. -- Barrons.com

Dow Jones
·
Sep 16

Bank of America Securities Sticks to Its Sell Rating for Hims & Hers Health (HIMS)

TIPRANKS
·
Sep 15

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Ocugen, Union Pacific

Reuters
·
Sep 15